Have a personal or library account? Click to login
Survival Study in Pediatric Patients with Medulloblastoma in a General Hospital in Tehran, Iran Cover

Survival Study in Pediatric Patients with Medulloblastoma in a General Hospital in Tehran, Iran

Open Access
|Jul 2022

Figures & Tables

Figure 1

Overall survival rates of pediatric patients with medulloblastoma according to age factors using the Kaplan–Meier curves and log-rank tests.
Overall survival rates of pediatric patients with medulloblastoma according to age factors using the Kaplan–Meier curves and log-rank tests.

Figure 2

Kaplan–Meier curves showing overall survival rates among 22 pediatric patients with medulloblastoma.
Kaplan–Meier curves showing overall survival rates among 22 pediatric patients with medulloblastoma.

Recurrence of patients_

Frequency%
Without recurrenceAlive,1777.3
RecurrenceAfter 2 years29.1
After 4 months29.1
After 9 months14.5
Total22100.0

Cause of death_

Frequency%
CauseBrain death, disease-related14.54
Infection14.54
Death due to progression29.09
Tumour regrowth and fever and seizures14.54
Tumour regrowth between brain and cerebellum14.54
Upper gastrointestinal bleeding14.54
Total731.79

Patient characteristics (n = 22)_

FactorMedulloblastoma No.%
Age (years), range8 (1–14)
Gender
Male1359.09
Female940.90
Clinical presentation
Headache1777.2
Vomiting1881.8
Lack of balance1045.4
Vision problems418.1
Dizziness522.7
Anaesthesia of the hands and feet14.5
Follow-up time (M ± SD)49.36 ± 38.33
Pathological type
Classic1359.09
Desmoplastic14.50
Large cell/anaplastic836.30
Tumour size (M ± SD)2.88 ± 1.319
Tumour location
Cerebellum1568.1
Posterior fossa313.6
Fourth ventricle313.6
Brain stem14.5
Tumour size before surgery, cm
< 31359.09
≥ 3940.90
Chemotherapy
Yes1986.3
No313.6
End of follow-up
status
Deceased731.8
Alive1568.1
DOI: https://doi.org/10.2478/fco-2021-0004 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 34 - 39
Submitted on: Sep 24, 2020
Accepted on: Apr 22, 2021
Published on: Jul 4, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year

© 2022 Sahel Valadan Tahbaz, Hossein Yahyazadeh, Marzieh Beheshti, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.